Design and characterization of helical peptides that inhibit the E6 protein of papillomavirus

Biochemistry

Volumn 43, Issue 23, 2004, Pages 7421-7431

  Liu, Yuqi ^a   Liu, Zhiguo ^b,c   Androphy, Elliot ^b   Chen, Jason ^b   Baleja, James D ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; COMPLEXATION; CONFORMATIONS; PROTEINS; SOLUTIONS; VIRUSES;

CIRCULAR DICHROISM SPECTROSCOPY; MOTIFS;

BIOCHEMISTRY;

CHIMERIC PROTEIN; HELICAL PEPTIDE; LEUCINE; LEUCYLGLUTAMINYLGLUTAMYLLEUCYLLEUCYLGLYCYLGLUTAMINE; LIGAND; MONOMER; PEPTIDE; PROTEIN; PROTEIN E6; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHA HELIX; AQUEOUS SOLUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; CONSENSUS SEQUENCE; HUMAN PAPILLOMAVIRUS TYPE 16; MOLECULAR STABILITY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PAPILLOMA VIRUS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN FOLDING; PROTEIN GRAFTING; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; TECHNIQUE; ZINC FINGER MOTIF;

BINDING SITES; CIRCULAR DICHROISM; DRUG DESIGN; INHIBITORY CONCENTRATION 50; MAGNETIC RESONANCE SPECTROSCOPY; MODELS, MOLECULAR; ONCOGENE PROTEINS, VIRAL; PEPTIDES; PROTEIN BINDING; PROTEIN DENATURATION; PROTEIN STRUCTURE, TERTIARY; REPRESSOR PROTEINS; TEMPERATURE;

PAPILLOMAVIRUS;

EID: 2942625637     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi049552a     Document Type: Article

References (59)

1. zur Hausen, H. (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184, 9-13.
2. Scheffner, M., Huibregtse, J. M., and Howley, P. M. (1994) Identification of a human ubiquitin-conjugating enzyme that mediates the E6-AP-dependent ubiquitination of p53. Proc. Natl. Acad. Sci. U.S.A. 91, 8797-8801.
3. Barbosa, M. S., Lowy, D. R., and Schiller, J. T. (1989) Papillomavirus polypeptides E6 and E7 are zinc-binding proteins. J. Virol. 63, 1404-1407.
4. Grossman, S. R. and Laimins, L. A. (1989) E6 protein of human papillomavirus type 18 binds zinc. Oncogene 4, 1089-1093.
5. Lipari, F., McGibbon, G. A., Wardrop, E., and Cordingley, M. G. (2001) Purification and biophysical characterization of a minimal functional domain and of an N-terminal Zn2+-binding fragment from the human papillomavirus type 16 E6 protein. Biochemistry 40, 1196-1204.
6. Ristriani, T., Nomine, Y., Masson, R., Weiss, E., and Trave, G. (2001) Specific recognition of four-way DNA junctions by the C-terminal zinc-binding domain of HPV oncoprotein E6. J. Mol. Biol. 305, 729-739.
7. Scheffner, M., Werness, B. A., Huibregtse, I. M., Levine, A. J., and Howley, P. M. (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63, 1129-1136.
8. Huibregtse, J. M., Scheffner, M., and Howley, P. M. (1994) E6-AP directs the HPV E6-dependent inactivation of p53 and is representative of a family of structurally and functionally related proteins. Cold Spring Harb. Symp. Quant. Biol. 59, 237-245.
9. Scheffner, M., Huibregtse, J. M., Vierstra, R. D., and Howley, P. M. (1993) The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53. Cell 75, 495-505.
10. Chen, J. J., Reid, C. E., Band, V., and Androphy, E. J. (1995) Interaction of papillomavirus E6 oncoproteins with a putative calcium-binding protein. Science 269, 529-531.
11. Du, M., Fan, X., Hong, E., and Chen, J. J. (2002) Interaction of oncogenic papillomavirus E6 proteins with fibulin-1. Biochem. Biophys. Res. Commun. 296, 962-969.
12. Zimmermann, H., Koh, C. H., Degenkolbe, R., O'Connor, M. J., Muller, A., Steger, G., Chen, J. J., Lui, Y., Androphy, E., and Bernard, H. U. (2000) Interaction with CBP/p300 enables the bovine papillomavirus type 1 E6 oncoprotein to downregulate CBP/p300-mediated transactivation by p53. J. Gen. Virol. 81, 2617-2623.
13. Degenhardt, Y. Y. and Silverstein, S. (2001) Interaction of zyxin, a focal adhesion protein, with the E6 protein from human papillomavirus type 6 results in its nuclear translocation. J. Virol. 75, 11791-11802.
14. Thomas, M., Glaunsinger, B., Pim, D., Javier, R., and Banks, L. (2001) HPV E6 and MAGUK protein interactions: determination of the molecular basis for specific protein recognition and degradation. Oncogene 20, 5431-5439.
15. Kiyono, T., Hiraiwa, A., Fujita, M., Hayashi, Y., Akiyama, T., and Ishibashi, M. (1997) Binding of high-risk human papillomavirus E6 oncoproteins to the human homologue of the Drosophila discs large tumor suppressor protein. Proc. Natl. Acad. Sci. U.S.A. 94, 11612-11616.
16. Vande Pol, S. B., Brown, M. C., and Turner, C. E. (1998) Association of Bovine Papillomavirus Type 1 E6 oncoprotein with the focal adhesion protein paxillin through a conserved protein interaction motif. Oncogene 16, 43-52.
17. Tong, X., Salgia, R., Li, J. L., Griffin, J. D., and Howley, P. M. (1997) The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase, J. Biol. Chem. 272, 33373-33376.
18. Tong, X., Boll, W., Kirchhausen, T., and Howley, P. M. (1998) Interaction of the bovine papillomavirus E6 protein with the clathrin adaptor complex AP-1. J. Virol. 72, 476-482.
19. Thomas, M. and Banks, L. (1999) Human papillomavirus (HPV) E6 interactions with Bak are conserved amongst E6 proteins from high and low risk HPV types. J. Gen. Virol. 80, 1513-1517.
20. Thomas, M. and Banks, L. (1998) Inhibition of Bak-induced apoptosis by HPV-18 E6. Oncogene 17, 2943-2954.
21. Gao, Q., Srinivasan, S., Boyer, S. N., Wazer, D. E., and Band, V. (1999) The E6 oncoproteins of high-risk papillomaviruses bind to a novel putative GAP protein, E6TP1, and target it for degradation. Mol. Cell Biol. 19, 733-744.
22. Li, S., Labrecque, S., Gauzzi, M. C., Cuddihy, A. R., Wong, A. H., Pellegrini, S., Matlashewski, G. J., and Koromilas, A. E. (1999) The human papilloma virus (HPV)-18 E6 oncoprotein physically associates with Tyk2 and impairs Jak-STAT activation by interferon-alpha. Oncogene 18, 5727-5737.
23. Nakagawa, S. and Huibregtse, J. M. (2000) Human scribble (Vartul) is targeted for ubiquitin-mediated degradation by the high-risk papillomavirus E6 proteins and the E6AP ubiquitin-protein ligase. Mol. Cell Biol. 20, 8244-8253.
24. Filippova, M., Song, H., Connolly, J. L., Dermody, T. S., and Duerksen-Hughes, P. J. (2002) The human papillomavirus 16 E6 protein binds to tumor necrosis factor (TNF) R1 and protects cells from TNF-induced apoptosis. J. Biol. Chem. 277, 21730-21739.
25. Ristriani, T., Masson, M., Nomine, Y., Laurent, C., Lefevre, J. F., Weiss, E., and Trave, G. (2000) HPV oncoprotein E6 is a structure-dependent DNA-binding protein that recognizes four-way junctions. J. Mol. Biol. 296, 1189-1203.
26. Be, X., Hong, Y., Wei, I., Androphy, E. I., Chen, J. I., and Baleja, J. D. (2001) Solution structure determination and mutational analysis of the papillomavirus E6 interacting peptide of E6AP. Biochemistry 40, 1293-1299.
27. Chen, J. J., Hong, Y., Rustamzadeh, E., Baleja, J. D., and Androphy, E. J. (1998) Identification of an alpha helical motif sufficient for association with papillomavirus E6. J. Biol. Chem. 273, 13537-13544.
28. Bohl, J., Das, K., Dasgupta, B., and Vande Pol, S. B. (2000) Competitive binding to a charged leucine motif represses transformation by a papillomavirus E6 oncoprotein. Virology 271, 163-170.
29. Hoellerer, M. K., Noble, M. E., Labesse, G., Campbell, I. D., Werner, J. M., and Arold, S. T. (2003) Molecular recognition of paxillin LD motifs by the focal adhesion targeting domain. Structure 11, 1207-1217.
30. Wright, P. E. and Dyson, H. J. (1999) Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J. Mol. Biol. 293, 321-331.
31. Bohm, G., Muhr, R., and Jaenicke, R. (1992) Quantitative analysis of protein far UV circular dichroism spectra by neural networks. Protein Eng. 5, 191-195.
32. Cavanagh, J. (1996) Protein NMR Spectroscopy: Principles and Practice Academic Press, San Diego.
33. Wüthrich, K. (1986) NMR of Proteins and Nucleic Acids Wiley, New York.
34. Neidigh, J. W., Fesinmeyer, R. M., and Andersen, N. H. (2002) Designing a 20-residue protein. Nat. Struct. Biol. 9, 425-430.
35. Neidigh, J. W., Fesinmeyer, R. M., Prickett, K. S., and Andersen, N. H. (2001) Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states. Biochemistry 40, 13188-13200.
36. Koradi, R., Billeter, M., and Wüthrich, K. (1996) MOLMOL: a program for display and analysis of macromolecular structures. J. Mol. Graph. 14, 51-55.
37. Sterlinko Grm, H., Weber, M., Elston, R., McIntosh, P., Griffin, H., Banks, L., and Doorbar, J. (2004) Inhibition of E6-induced degradation of its cellular substrates by novel blocking peptides. J. Mol. Biol. 335, 971-985.
38. Nomine, Y., Ristriani, T., Laurent, C., Lefevre, J. F., Weiss, E., and Trave, G. (2001) Formation of soluble inclusion bodies by HPV E6 oncoprotein fused to maltose-binding protein. Protein Expression Purif. 23, 22-32.
39. Nomine, Y., Ristriani, T., Laurent, C., Lefevre, J. F., Weiss, E., and Trave, G. (2001) A strategy for optimizing the monodispersity of fusion proteins: application to purification of recombinant HPV E6 oncoprotein. Protein Eng. 14, 297-305.
40. Degenkolbe, R., Gilligan, P., Gupta, S., and Bernard, H. U. (2003) Chelating agents stabilize the monomeric state of the zinc binding human papillomavirus 16 E6 oncoprotein. Biochemistry 42, 3868-3873.
41. Narayan, V. A., Kriwacki, R. W., and Caradonna, J. P. (1997) Structures of zinc finger domains from transcription factor Sp1. Insights into sequence-specific protein-DNA recognition. J. Biol. Chem. 272, 7801-7809.
42. Kriwacki, R. W., Schultz, S. C., Steitz, T. A., and Caradonna, J. P. (1992) Sequence-specific recognition of DNA by zinc-finger peptides derived from the transcription factor Sp1. Proc. Natl. Acad. Sci. U.S.A. 89, 9759-9763.
43. Frankel, A. D., Berg, J. M., and Pabo, C. O. (1987) Metal-dependent folding of a single zinc finger from transcription factor IIIA. Proc. Natl. Acad. Sci. U.S.A. 84, 4841-4845.
44. Kuwahara, J. and Coleman, J. E. (1990) Role of the zinc(II) ions in the structure of the three-finger DNA binding domain of the Sp1 transcription factor. Biochemistry 29, 8627-8631.
45. Sia, S. K., Carr, P. A., Cochran, A. G., Malashkevich, V. N., and Kim, P. S. (2002) Short constrained peptides that inhibit HIV-1 entry. Proc. Natl. Acad. Sci. U.S.A. 99, 14664-14669.
46. Arumugam, S., Gao, G., Patton, B. L., Semenchenko, V., Brew, K., and Van Doren, S. R. (2003) Increased backbone mobility in beta-barrel enhances entropy gain driving binding of N-TIMP-1 to MMP-3. J. Mol. Biol. 327, 719-734.
47. Merutka, G., Dyson, H. J., and Wright, P. E. (1995) Random coil H-1 chemical-shifts obtained as a function of temperature and trifluoroethanol concentration for the peptide series GGXGG. J. Biomol. NMR 5, 14-24.
48. Wishart, D. S., Bigam, C. G., Yao, J., Abildgaard, F., Dyson, H. J., Oldfield, E., Markley, J. L., and Sykes, B. D. (1995) H-1, C-13 and N-15 chemical-shift referencing in biomolecular NMR. J. Biomol. NMR 6, 135-140.
49. Hyberts, S. G., Goldberg, M. S., Havel, T. F., and Wagner, G. (1992) The solution structure of eglin c based on measurements of many NOEs and coupling constants and its comparison with X-ray structures. Protein Sci. 1, 736-751.
50. Szyperski, T., Guntert, P., and Otting, G. (1992) Determination of Scalar Coupling-Constants by Inverse Fourier Transformation of In-Phase Multiplets. J. Magn. Reson. 99, 552-560.
51. Mayer, K. L. and Stone, M. J. (2000) NMR solution structure and receptor peptide binding of the CC chemokine eotaxin-2. Biochemistry 39, 8382-8395.
52. Akke, M., Forsen, S., and Chazin, W. J. (1995) Solution structure of (Cd2+)1-calbindin D9k reveals details of the stepwise structural changes along the Apo→(Ca2+)II1→(Ca2+)I,II2 binding pathway. J. Mol. Biol. 252, 102-121.
53. Paakkonen, K., Annila, A., Sorsa, T., Pollesello, P., Tilgmann, C., Kilpelainen, I., Karisola, P., Ulmanen, I., and Drakenberg, T. (1998) Solution structure and main chain dynamics of the regulatory domain (residues 1-91) of human cardiac troponin C. J. Biol. Chem. 273, 15633-15638.
54. Cui, B., Shen, M. Y., and Freed, K. F. (2003) Folding and misfolding of the papillomavirus E6 interacting peptide E6ap. Proc. Natl. Acad. Sci. U.S.A. 100, 7087-7092.
55. Luidens, M. K., Figge, J., Breese, K., and Vajda, S. (1996) Predicted and trifluoroethanol-induced alpha-helicity of polypeptides. Biopolymers 39, 367-376.
56. Main, E. R. and Jackson, S. E. (1999) Does trifluoroethanol affect folding pathways and can it be used as a probe of structure in transition states? Nat. Struct. Biol. 6, 831-835.
57. Ionescu, R. M. and Matthews, C. R. (1999) Folding under the influence. Nat. Struct. Biol. 6, 304-307.
58. Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., Fotouhi, N., and Liu, E. A. (2004) In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303, 844-848.
59. Rutledge, S. E., Volkman, H. M., and Schepartz, A. (2003) Molecular recognition of protein surfaces: high affinity ligands for the CBP KIX domain. J. Am. Chem. Soc. 125, 14336-14347.